Significant SEND
Contract Expansion

A global provider of leading software solutions
and services to the life sciences community.

Helping our clients bring life enhancing products to market faster.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.


Latest News

24 May 2018 - Result of AGM

Read More

26 March 2018 - Unaudited Results for the Year Ended 31 December 2017

Read More

26 March 2018 - SEND Contract Extension and SEND Update

Read More

Annual Report 2016

A Decade in Perspective

Annual Report 2016

We have maintained our pre-eminent position in the preclinical market and taken further market share in the now FDA mandated SEND market.

A Decade in Perspective

…and opportunities in technology-enabled outsourced services
Research Note by Gareth Evans of Progressive Equity Research